Proportion of isolates with decreased susceptibility or resistance in United States of America

United States of America: Proportion of isolates with decreased susceptibility or resistance was 0.2907 in 2018. ◆ Volatile

Latest (2018)
0.2907
Change on year
down 33.1%
World rank
14th
of 27 countries
All-time high
0.7993
in 2009
All-time low
0.091
in 2012
Years of data
10
2009–2018

Proportion of isolates with decreased susceptibility or resistance in United States of America, 2009–2018

00.20.40.60.82009201320182009: 0.7992010: 0.1412011: 0.1282012: 0.0912013: 0.4042014: 0.7462015: 0.4862016: 0.3232017: 0.4352018: 0.291

Source: World Health Organization, Global Health Observatory.

Analysis

In 2018, proportion of isolates with decreased susceptibility or resistance in United States of America stood at 0.2907.

Compared with earlier readings it is down 33.1% on the previous year and down 63.6% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in United States of America peaked at 0.7993 in 2009 and was at its lowest, 0.091, in 2012.

That places United States of America 14th out of 27 countries with data for 2018, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in United States of America, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP in United States of America, 2009 to 2018.
Year Value Change
2009 0.7993
2010 0.1405 -82.4%
2011 0.128 -8.9%
2012 0.091 -28.9%
2013 0.4037 +343.7%
2014 0.7461 +84.8%
2015 0.4857 -34.9%
2016 0.3234 -33.4%
2017 0.4347 +34.4%
2018 0.2907 -33.1%

United States of America compared with similar countries

  • United States of America's 0.2907 is above the median for high income countries, which is 0.2907, 1.0× the median. (25 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.7993 0.7993 0.7993 1
2010s 0.3382 0.091 0.7461 9

Countries ranked near United States of America

  1. 11 United Kingdom of Great Britain and Northern Ireland 1.2 compare
  2. 12 Germany 1 compare
  3. 13 Canada 0.5445 compare
  4. 15 Estonia 0
  5. 15 Malta 0 compare
  6. 15 France 0 compare
  7. 15 Netherlands 0 compare
  8. 15 Slovakia 0 compare
  9. 15 Slovenia 0 compare
  10. 15 Iceland 0
  11. 15 Latvia 0 compare
  12. 15 Portugal 0 compare
  13. 15 Ireland 0 compare
  14. 15 Norway 0 compare
  15. 15 Côte d'Ivoire 0
  16. 15 Denmark 0 compare

See the full ranking of 27 places →

More health data for United States of America

All data for United States of America →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in United States of America?
Proportion of isolates with decreased susceptibility or resistance in United States of America was 0.2907 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in United States of America?
The highest recorded value was 0.7993 in 2009.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in United States of America?
The lowest recorded value was 0.091 in 2012.
How does United States of America rank for proportion of isolates with decreased susceptibility or resistance?
United States of America ranks 14th out of 27 countries with data for 2018.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in United States of America?
Over the last ten years it is down 63.6%. The long-run trend across the full record is volatile.
Where does this United States of America data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in United States of America. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 13 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/united-states/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/united-states/">Proportion of isolates with decreased susceptibility or resistance in United States of America</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
27 places, 246 data points, 2009–2018
Last refreshed